Continuous hemodynamic monitoring in heart failure

Journal of Cardiovascular Electrophysiology

Volumn 13, Issue 1 SUPPL., 2002, Pages

  Braunschweig, Frieder ^a   Linde, Cecilia ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ambulatory monitoring; Beta blocker; Congestive heart failure; Diuretic; Hemodynamics; Therapy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT;

ADULT; AMBULATORY MONITORING; BODY FLUID; CASE REPORT; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DEVICE; FLUID THERAPY; HEALTH CARE COST; HEMODYNAMIC MONITORING; HUMAN; MALE; MORBIDITY; MORTALITY; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; TITRIMETRY; TREATMENT PLANNING;

EID: 0036155098     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2002.tb01957.x     Document Type: Conference Paper

References (24)

1. Changing epidemiological features of cardiac failure
2. The epidemiology of heart failure
3. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
4. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators
5. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
6. A randomised trial
7. Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
8. Effect of carvedilol on survival in severe chronic heart failure
9. The economic burden of heart failure
10. The health care costs of heart failure in Sweden
11. From cost of illness to cost-effectiveness in heart failure
12. Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique
13. Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable hemodynamic monitor: Results of a one year multicenter feasibility study
14. Long term follow-up with the chronicle implantable haemodynamic monitor: 12 Month results from a multicenter feasibility trial in heart failure patients
15. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure
16. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): Design and rationale
17. The effectiveness of right heart catheterization in the initial care of critically ill patients
18. Monitoring of pulmonary arterial diastolic pressure through a right ventricular pressure transducer
19. Measurement of pulmonary artery diastolic pressure from a right ventricular pressure transducer in patients with heart failure
20. The treatment of heart failure
21. Patients self-assessment of their heart failure: Content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire
22. Untreated heart failure: Clinical and neuroendocrine effects of introducing diuretics
23. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy
24. Continuous hemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure